mTOR Inhibition Ablates Cisplatin-Resistant Salivary Gland Cancer Stem Cells

BMI1 Inhibition Eliminates Residual Cancer Stem Cells after PD1 Blockade and Activates Antitumor Immunity to Prevent Metastasis and Relapse

(2020) Lingfei Jia et al.   Cell Stem Cell

B591, a novel specific pan-PI3K inhibitor, preferentially targets cancer stem cells

(2019) Hongyu Zhou et al.   ONCOGENE

Targeting mTOR and Metabolism in Cancer: Lessons and Innovations

(2019) Cedric Magaway et al.   Cells

B lymphoma Moloney murine leukemia virus insertion region 1: An oncogenic mediator in prostate cancer

(2018) Qi Cao et al.   ASIAN JOURNAL OF ANDROLOGY

Blocking Stemness and Metastatic Properties of Ovarian Cancer Cells by Targeting p70 S6K with Dendrimer Nanovector-Based siRNA Delivery

(2018) Jing Ma et al.   MOLECULAR THERAPY

Ablation of Cancer Stem Cells by Therapeutic Inhibition of the MDM2–p53 Interaction in Mucoepidermoid Carcinoma

(2018) April Andrews et al.   CLINICAL CANCER RESEARCH

Akt Signaling Pathway in Macrophage Activation and M1/M2 Polarization

(2017) Eleni Vergadi et al.   JOURNAL OF IMMUNOLOGY

Systemic therapy in metastatic salivary gland carcinomas: A pathology-driven paradigm?

(2017) Salvatore Alfieri et al.   ORAL ONCOLOGY

Targeting aldehyde dehydrogenase activity in head and neck squamous cell carcinoma with a novel small molecule inhibitor

(2017) Jeewon Kim et al.   Oncotarget

Therapeutic Inhibition of the MDM2–p53 Interaction Prevents Recurrence of Adenoid Cystic Carcinomas

(2016) Felipe Nör et al.   CLINICAL CANCER RESEARCH

Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2

(2016) Stephen B. Keysar et al.   JNCI-Journal of the National Cancer Institute

Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2

(2016) Stephen B. Keysar et al.   JNCI-Journal of the National Cancer Institute

Effects of PI3K inhibitor NVP-BKM120 on overcoming drug resistance and eliminating cancer stem cells in human breast cancer cells

(2015) Y Hu et al.   Cell Death & Disease

ALDH/CD44 identifies uniquely tumorigenic cancer stem cells in salivary gland mucoepidermoid carcinomas

(2015) April Adams et al.   Oncotarget

Cisplatin Induces Bmi-1 and Enhances the Stem Cell Fraction in Head and Neck Cancer

(2015) Carolina Nör et al.   NEOPLASIA

Cancer stem cells: Mediators of tumorigenesis and metastasis in head and neck squamous cell carcinoma

(2014) Steven B. Chinn et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Activation of the PI3K/mTOR/AKT Pathway and Survival in Solid Tumors: Systematic Review and Meta-Analysis

(2014) Alberto Ocana et al.   PLoS One

Recent trends in the management of minor salivary gland carcinoma

(2013) Vincent Vander Poorten et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Salivary gland cancer stem cells

(2013) April Adams et al.   ORAL ONCOLOGY

Akt-mediated phosphorylation of Bmi1 modulates its oncogenic potential, E3 ligase activity, and DNA damage repair activity in mouse prostate cancer

(2012) Karim Nacerddine et al.   JOURNAL OF CLINICAL INVESTIGATION

Activation of an IL6 Inflammatory Loop Mediates Trastuzumab Resistance in HER2+ Breast Cancer by Expanding the Cancer Stem Cell Population

(2012) Hasan Korkaya et al.   MOLECULAR CELL

A restricted cell population propagates glioblastoma growth after chemotherapy

(2012) Jian Chen et al.   NATURE

The biology of head and neck cancer stem cells

(2011) Zhaocheng Zhang et al.   ORAL ONCOLOGY

Aldehyde Dehydrogenase 1-Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast Cancer

(2009) E. Charafe-Jauffret et al.   CLINICAL CANCER RESEARCH

Association of reactive oxygen species levels and radioresistance in cancer stem cells

(2009) Maximilian Diehn et al.   NATURE